ASX - By Stock
|
RSG |
Re:
$1 dollar club
|
|
Sentisure
|
13 |
6.1K |
3 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
13
|
6.1K
|
3
|
|
ASX - By Stock
|
COE |
Re:
Ann: BMG Wells decommissioning complete
|
|
Sentisure
|
3 |
1.1K |
9 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
3
|
1.1K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Sentisure
|
873 |
334K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
873
|
334K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
Sentisure
|
160 |
78K |
29 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
78K
|
29
|
|
ASX - By Stock
|
ADT |
Re:
Ann: Investor Presentation
|
|
Sentisure
|
22 |
8.7K |
4 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
22
|
8.7K
|
4
|
|
ASX - By Stock
|
SYA |
Re:
Ann: Moblan drilling delivers thick, high-grade intersections
|
|
Sentisure
|
107 |
49K |
10 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
107
|
49K
|
10
|
|
ASX - By Stock
|
COE |
Re:
Ann: BMG Wells decommissioning update
|
|
Sentisure
|
12 |
4.2K |
2 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
12
|
4.2K
|
2
|
|
ASX - By Stock
|
COE |
Re:
Ann: BMG Wells decommissioning update
|
|
Sentisure
|
12 |
4.2K |
6 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
12
|
4.2K
|
6
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Sentisure
|
140K |
53M |
30 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
140K
|
53M
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Sentisure
|
13K |
6.6M |
9 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
13K
|
6.6M
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Presents New Data on ATH434
|
|
Sentisure
|
20 |
6.2K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
20
|
6.2K
|
12
|
|
ASX - By Stock
|
TBN |
Re:
Ann: SS-1H achieved final IP90 commercial flow rates
|
|
Sentisure
|
19 |
6.6K |
5 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
19
|
6.6K
|
5
|
|
ASX - By Stock
|
SYA |
Re:
Ann: New High-Grade Zones Discovered at North American Lithium
|
|
Sentisure
|
101 |
45K |
7 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
101
|
45K
|
7
|
|
ASX - By Stock
|
LOT |
Re:
Uranium news
|
|
Sentisure
|
84 |
39K |
0 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
84
|
39K
|
0
|
|
ASX - By Stock
|
MEI |
Re:
Meteoric Resources - Caldeira Review
|
|
Sentisure
|
14 |
5.1K |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
14
|
5.1K
|
5
|
|
ASX - By Stock
|
MEI |
Re:
General discussion (MEI)
|
|
Sentisure
|
4.8K |
1.8M |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
4.8K
|
1.8M
|
7
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Investor Presentation
|
|
Sentisure
|
35 |
10K |
8 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
35
|
10K
|
8
|
|
ASX - By Stock
|
EMP |
Re:
Ann: Results of Judith-1 Well Gas Production Simulation Modelling
|
|
Sentisure
|
24 |
5.6K |
0 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
24
|
5.6K
|
0
|
|
ASX - By Stock
|
COE |
Re:
Ann: Q3 FY24 Quarterly Report
|
|
Sentisure
|
10 |
5.1K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
10
|
5.1K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Medium term milestones
|
|
Sentisure
|
89 |
45K |
20 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
89
|
45K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
Sentisure
|
144 |
67K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
67K
|
5
|
|
ASX - By Stock
|
COE |
Re:
Ann: Q3 Quarterly report conference call details
|
|
Sentisure
|
2 |
1.2K |
11 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
2
|
1.2K
|
11
|
|
ASX - By Stock
|
IDX |
Re:
Ann: Half Year Results Investor Presentation
|
|
Sentisure
|
11 |
6.7K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
11
|
6.7K
|
0
|
|
ASX - By Stock
|
COE |
Re:
Ann: Market Update
|
|
Sentisure
|
13 |
5.9K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
13
|
5.9K
|
5
|
|
ASX - By Stock
|
MEI |
Re:
General discussion (MEI)
|
|
Sentisure
|
4.8K |
1.8M |
12 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
4.8K
|
1.8M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Sentisure
|
13K |
6.6M |
17 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13K
|
6.6M
|
17
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
56
|
22K
|
2
|
|
ASX - By Stock
|
RIC |
Re:
Ann: Change in substantial holding
|
|
Sentisure
|
2 |
706 |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
2
|
706
|
2
|
|
ASX - By Stock
|
LOT |
Re:
Ann: Appointment of Debt Advisor for Kayelekera Restart
|
|
Sentisure
|
3 |
1.2K |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
3
|
1.2K
|
7
|
|
ASX - By Stock
|
MEI |
Re:
General discussion (MEI)
|
|
Sentisure
|
4.8K |
1.8M |
15 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
4.8K
|
1.8M
|
15
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
5 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
56
|
22K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Sentisure
|
873 |
334K |
5 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
873
|
334K
|
5
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
56
|
22K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
Sentisure
|
78 |
25K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
25K
|
5
|
|
ASX - By Stock
|
COE |
Re:
Ann: Cooper Energy H1 FY24 results presentation
|
|
Sentisure
|
56 |
22K |
6 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
56
|
22K
|
6
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Largest ever single order
|
|
Sentisure
|
94 |
37K |
6 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
94
|
37K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
|
|
Sentisure
|
104 |
59K |
17 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
104
|
59K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Sentisure
|
316 |
163K |
25 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
316
|
163K
|
25
|
|
ASX - By Stock
|
ATH |
Re:
Finally Moving North
|
|
Sentisure
|
15 |
3.7K |
2 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
15
|
3.7K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Phase 2 DMC Recommends Continuing Clinical Trial as Planned
|
|
Sentisure
|
8 |
2.7K |
5 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8
|
2.7K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Sentisure
|
380 |
128K |
6 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
128K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Sentisure
|
9.7K |
2.9M |
15 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
9.7K
|
2.9M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
Sentisure
|
51 |
33K |
19 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
51
|
33K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Entitlement Offer and Placement Investor Presentation
|
|
Sentisure
|
48 |
15K |
3 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
48
|
15K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Sentisure
|
210 |
88K |
4 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
88K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
Sentisure
|
210 |
88K |
9 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
210
|
88K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
Sentisure
|
315 |
157K |
9 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
157K
|
9
|
|